Tolerance Bio. ^Investors

Biopharmaceutical companyВідповідно до джерел: 2Tolerance Bio is a biopharmaceutical company focused on manipulating immune tolerance via the thymus. Tolerance Bio completed a $ million seed funding round to advance thymus-based therapies for Bio - Bio, Inc., is a biopharmaceutical company focused on manipulating immune tolerance via the thymus to address various immune-mediated diseases. The company is based in Philadelphia, PA. For more Bio, Inc.